Literature DB >> 25703487

Updated meta-analysis of classical fear conditioning in the anxiety disorders.

Puck Duits1, Danielle C Cath, Shmuel Lissek, Joop J Hox, Alfons O Hamm, Iris M Engelhard, Marcel A van den Hout, Joke M P Baas.   

Abstract

The aim of the current study was twofold: (1) to systematically examine differences in fear conditioning between anxiety patients and healthy controls using meta-analytic methods, and (2) to examine the extent to which study characteristics may account for the variability in findings across studies. Forty-four studies (published between 1920 and 2013) with data on 963 anxiety disordered patients and 1,222 control subjects were obtained through PubMed and PsycINFO, as well as from a previous meta-analysis on fear conditioning (Lissek et al.). Results demonstrated robustly increased fear responses to conditioned safety cues (CS-) in anxiety patients compared to controls during acquisition. This effect may represent an impaired ability to inhibit fear in the presence of safety cues (CS-) and/or may signify an increased tendency in anxiety disordered patients to generalize fear responses to safe stimuli resembling the conditioned danger cue (CS+). In contrast, during extinction, patients show stronger fear responses to the CS+ and a trend toward increased discrimination learning (differentiation between the CS+ and CS-) compared to controls, indicating delayed and/or reduced extinction of fear in anxiety patients. Finally, none of the included study characteristics, such as the type of fear measure (subjective vs. psychophysiological index of fear), could account significantly for the variance in effect sizes across studies. Further research is needed to investigate the predictive value of fear extinction on treatment outcome, as extinction processes are thought to underlie the beneficial effects of exposure treatment in anxiety disorders.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  anxiety disorders; classical fear conditioning; extinction; meta-analysis

Mesh:

Year:  2015        PMID: 25703487     DOI: 10.1002/da.22353

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  150 in total

Review 1.  Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions.

Authors:  Michael W Otto; M Alexandra Kredlow; Jasper A J Smits; Stefan G Hofmann; David F Tolin; Rianne A de Kleine; Agnes van Minnen; A Eden Evins; Mark H Pollack
Journal:  Biol Psychiatry       Date:  2015-09-25       Impact factor: 13.382

2.  Converging evidence for an impact of a functional NOS gene variation on anxiety-related processes.

Authors:  Manuel Kuhn; Jan Haaker; Evelyn Glotzbach-Schoon; Dirk Schümann; Marta Andreatta; Marie-Luise Mechias; Karolina Raczka; Nina Gartmann; Christian Büchel; Andreas Mühlberger; Paul Pauli; Andreas Reif; Raffael Kalisch; Tina B Lonsdorf
Journal:  Soc Cogn Affect Neurosci       Date:  2016-01-08       Impact factor: 3.436

3.  [The German research network for mental disorders].

Authors:  M Bauer; T Banaschewski; A Heinz; I Kamp-Becker; A Meyer-Lindenberg; F Padberg; M A Rapp; R Rupprecht; F Schneider; T G Schulze; H-U Wittchen
Journal:  Nervenarzt       Date:  2016-09       Impact factor: 1.214

4.  Colon-delivered short-chain fatty acids attenuate the cortisol response to psychosocial stress in healthy men: a randomized, placebo-controlled trial.

Authors:  Bram Vervliet; Kristin Verbeke; Lukas Van Oudenhove; Boushra Dalile; Gabriela Bergonzelli
Journal:  Neuropsychopharmacology       Date:  2020-06-10       Impact factor: 7.853

5.  Skin Conductance Responses and Neural Activations During Fear Conditioning and Extinction Recall Across Anxiety Disorders.

Authors:  Marie-France Marin; Rachel G Zsido; Huijin Song; Natasha B Lasko; William D S Killgore; Scott L Rauch; Naomi M Simon; Mohammed R Milad
Journal:  JAMA Psychiatry       Date:  2017-06-01       Impact factor: 21.596

6.  Psychophysiological treatment outcomes: Corticotropin-releasing factor type 1 receptor antagonist increases inhibition of fear-potentiated startle in PTSD patients.

Authors:  Tanja Jovanovic; Erica J Duncan; Joanna Kaye; Kristie Garza; Seth D Norrholm; Sabra S Inslicht; Thomas C Neylan; Sanjay J Mathew; Dan Iosifescu; Barbara O Rothbaum; Helen S Mayberg; Boadie W Dunlop
Journal:  Psychophysiology       Date:  2019-02-26       Impact factor: 4.016

Review 7.  Extinction learning in childhood anxiety disorders, obsessive compulsive disorder and post-traumatic stress disorder: implications for treatment.

Authors:  Joseph F McGuire; Scott P Orr; Joey K-Y Essoe; James T McCracken; Eric A Storch; John Piacentini
Journal:  Expert Rev Neurother       Date:  2016-06-27       Impact factor: 4.618

8.  Heterogeneity in Fear Processing across and within Anxiety, Eating, and Compulsive Disorders.

Authors:  Abby J Fyer; Franklin R Schneier; Helen Blair Simpson; Tse Hwei Choo; Stephanie Tacopina; Marcia B Kimeldorf; Joanna E Steinglass; Melanie Wall; B Timothy Walsh
Journal:  J Affect Disord       Date:  2020-07-22       Impact factor: 4.839

9.  Heightened extended amygdala metabolism following threat characterizes the early phenotypic risk to develop anxiety-related psychopathology.

Authors:  A J Shackman; A S Fox; J A Oler; S E Shelton; T R Oakes; R J Davidson; N H Kalin
Journal:  Mol Psychiatry       Date:  2016-08-30       Impact factor: 15.992

10.  Neural correlates of and processes underlying generalized and differential return of fear.

Authors:  Robert Scharfenort; Tina B Lonsdorf
Journal:  Soc Cogn Affect Neurosci       Date:  2015-11-25       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.